ACPE Number: 0217-9999-23-068-H04-P
Content Release Date: 5/17/2023
Expiration Date: 11/15/2023
Activity Type: Application-based
CE Credits: 5.0 hours (BPS and ACPE)
Activity Fee: $175 (ASHP member); $275 (non-member)
This course is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.
This online activity is approved for 5.0 hours of continuing pharmacy education credit and/or recertification credit.
|The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.|
|The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.|
The target audience for this course is clinical pharmacists with an interest in statistics and trial design, clinical pharmacists who plan to sit for a BPS specialty exam, and clinical pharmacists wishing to earn recertification credit in Ambulatory Care Pharmacy.
Board certified pharmacists are eligible to receive up to 5.0 hours of recertification credit for completing this workshop. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
This course is not intended for those preparing to take the BPS Ambulatory Care Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/amb-care-review.
This activity is part of the ACCP and ASHP professional development program for BCACP recertification approved by the BPS.
For full program information, please visit: http://elearning.ashp.org/catalog/amb-care-recert
Contact Hours (ACPE and BPS)
Assessment Pass Point
Fundamentals of Biostatistics and Clinical Trial Design Workshop, 2023 Edition (Cert # L239230)
After participating in this CPE activity, learners should be able to:
- Describe hypothesis testing and state the meaning of and distinguish between p values and confidence intervals, and measures of central tendency and data spread.
- Delineate the key attributes of study variables (study data) and the primary levels/categories of data measurement (give examples of each). Develop examples of converting data from one level/category to another.
- Determine why a statistical test is appropriate or not appropriate, given the sample distribution, data type, and study design. Interpret statistical and clinical significance for results from commonly used statistical tests.
- Differentiate and recognize the designs and structures of key studies utilized in medical publications.
- Define and interpret key study-related concepts and terms.
- Describe and calculate the most important epidemiological terms associated with healthcare and research.
- Describe and calculate the key terms associated with healthcare screenings.
Mate M. Soric, Pharm.D., FCCP, BCPS
Chair and Professor
Department of Pharmacy Practice
Northeast Ohio Medical University College of Pharmacy
Clinical Pharmacy Specialist, Internal Medicine
University Hospitals Geauga Medical Center
Katie J. Suda, Pharm.D., M.S., FCCP
Research Health Scientist and Associate Director of Clinical Therapeutics
VA Center for Health Equity Research and Promotion
Tenured Professor of Medicine and Pharmacy & Therapeutics
Director, Transition to Independence Program
University of Pittsburg Schools of Medicine and Pharmacy
Brian Spoelhof, Pharm.D., BCCCP, BCPS
Tyler A. Vest, Pharm.D., BCPS, BCSCP
Evan Williams, Pharm.D., MBA, BCPS, BCACP
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.
This activity consists of audio and slides, a PDF book chapter, an attestation statement, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for the activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
ACCP and ASHP collaborate on ambulatory care activities.